Mariëtte I.E. van Poelgeest

High Number of Intraepithelial CD8+ Tumor-Infiltrating Lymphocytes Is Associated with the Absence of Lymph Node Metastases in Patients with Large Early-Stage Cervical Cancer

Sytse J. Piersma, Ekaterina S. Jordanova, Mariëtte I.E. van Poelgeest et al. · Cancer Research · 2007 · 419 citations

Life Sciences, Immunology, Oncology +17

Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6

Annemieke de Jong, Mariëtte I.E. van Poelgeest, Jeanette M. van der Hulst et al. · Cancer Research · 2004 · 310 citations

Medicine, Immunology, Oncology +17

A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer

E. M. Dijkgraaf, Saskia J. Santegoets, A.K.L. Reyners et al. · Annals of Oncology · 2015 · 193 citations

Medicine, Oncology, Pharmacology +14

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial

Mariëtte I.E. van Poelgeest, Marij J.P. Welters, Edith M.G. van Esch et al. · Journal of Translational Medicine · 2013 · 187 citations · Full text

Medicine, Immunology, Oncology +17

Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response

Mariëtte I.E. van Poelgeest, Marij J.P. Welters, Renee Vermeij et al. · Clinical Cancer Research · 2016 · 165 citations

Medicine, Immunology, Oncology +17